Demographics and clinical presentation in patients with COVID-19 pneumonia
Characteristics | Total | Deceased | Survivors | p-value |
Patients | 179 | 21 | 158 | |
Age years | 57.6±13.7 | 70.2±7.7 | 56.0±13.5 | <0.001 |
Sex | 0.642 | |||
Male | 97 (54.2) | 10 (47.6) | 87 (55.1) | |
Female | 82 (45.8) | 11 (52.4) | 71 (44.9) | |
Underlying diseases | ||||
Hypertension | 58 (32.4) | 13 (61.9) | 45 (28.5) | 0.005 |
Cardiovascular or cerebrovascular diseases | 29 (16.2) | 12 (57.1) | 17 (10.8) | <0.001 |
Diabetes | 33 (18.4) | 6 (28.6) | 27 (17.1) | 0.231 |
Chronic digestive disorders | 21 (11.7) | 4 (19.0) | 17 (10.8) | 0.279 |
Tuberculosis | 8 (4.5) | 0 (0) | 8 (5.1) | 0.599 |
Chronic hepatic or renal insufficiency | 4 (2.2) | 2 (9.5) | 2 (1.3) | 0.068 |
Peripheral vascular disease | 4 (2.2) | 2 (9.5) | 2 (1.3) | 0.068 |
Malignancy | 4 (2.2) | 1 (4.8) | 3 (1.9) | 0.396 |
Symptoms | ||||
Fever | 177 (98.9) | 21 (100) | 156 (98.7) | 1.000 |
Dry cough | 146 (81.6) | 14 (66.7) | 132 (83.5) | 0.074 |
Dyspnoea | 89 (49.7) | 18 (85.7) | 71 (44.9) | <0.001 |
Fatigue | 71 (39.7) | 13 (61.9) | 58 (36.7) | 0.033 |
Sputum production | 55 (30.7) | 12 (57.1) | 43 (27.2) | 0.010 |
Gastrointestinal symptoms | 39 (21.8) | 8 (38.1) | 31 (19.6) | 0.087 |
Myalgia | 34 (19.0) | 7 (33.3) | 27 (17.1) | 0.083 |
Headache | 17 (9.5) | 5 (23.8) | 12 (7.6) | 0.033 |
Haemoptysis | 10 (5.6) | 0 (0) | 10 (6.3) | 0.609 |
Systolic blood pressure mmHg | NA | 122.4±18.6 | ||
Diastolic blood pressure mmHg | NA | 77.9±10.0 | ||
Temperature °C | 0.156 | |||
<37.3 | 109 (60.9) | 16 (76.2) | 93 (58.9) | |
≥37.3 | 70 (39.1) | 5 (23.8) | 65 (41.1) | |
Respiratory rate breaths·min−1 | 20.0 (20.0–21.0) | 20.0 (20.0–34.5) | 20.0 (20.0–21.0) | 0.016 |
Heart rate beats·min−1 | 86.0 (78.0–100) | 94.0 (78.0–109.5) | 85.5 (78.0–99.3) | 0.150 |
Data are presented as n, mean±sd, n (%) or median (interquartile range), unless otherwise stated. NA: not available.